Although genetic testing and serum alpha-1 antitrypsin levels were unavailable, the histopathological findings strongly suggested alpha-1 antitrypsin deficiency as the underlying cause of pulmonary disease and the secondary development of systemic SAA-associated amyloidosis. The gene discussed is SERPINA1; the disease is amyloidosis.